An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine-Reference-Cited by-同舟云学术

An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine

Published:2014-06-23 Issue:14 Volume:5 Page:5218-5233
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Maldonado Leonel¹²,Brait Mariana¹,Michailidi Christina¹,Munari Enrico¹³,Driscoll Tina⁴,Schultz Luciana³,Bivalacqua Trinity⁴,Schoenberg Mark⁴,Sidransky David¹,Netto George J.³⁴,Hoque Mohammad Obaidul¹⁴⁵

Affiliation:

1. Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA

2. Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

3. Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA

4. Department of Urology, Johns Hopkins University, Baltimore, Maryland, USA

5. Department of Oncology, Johns Hopkins University, Baltimore, Maryland, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Test Accuracy of Urinary DNA Methylation-based Biomarkers for the Detection of Primary and Recurrent Bladder Cancer: A Systematic Review and Meta-analysis;European Urology Focus;2024-06

2. Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma;Journal of Cancer;2023

3. New Advances in the Prediction of NMIBC Recurrence by Genetic Biomarkers;Advances in Clinical Medicine;2023

4. Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends;Cancers;2022-10-14

5. Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?;Translational Andrology and Urology;2021-06